1. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus
- Author
-
P. Tomlinson, Tony Kouzarides, M P Cranage, Bart Barrell, Kathleen Weston, Alan T. Bankier, Anthony Charles Minson, H Hart, Susanne Bell, and Sandra C. Satchwell
- Subjects
Human cytomegalovirus ,Genes, Viral ,viruses ,Cytomegalovirus ,Fluorescent Antibody Technique ,Vaccinia virus ,Antibodies, Viral ,Recombinant virus ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Virus ,Cell Line ,Viral Envelope Proteins ,Neutralization Tests ,medicine ,Animals ,Humans ,Poxviridae ,Amino Acid Sequence ,Orthopoxvirus ,Molecular Biology ,Base Sequence ,General Immunology and Microbiology ,biology ,Viral culture ,General Neuroscience ,Varicella zoster virus ,Antibodies, Monoclonal ,Membrane Proteins ,virus diseases ,biochemical phenomena, metabolism, and nutrition ,biology.organism_classification ,medicine.disease ,Virology ,Herpes simplex virus ,Genes ,Research Article - Abstract
A human cytomegalovirus (HCMV) glycoprotein gene with homology to glycoprotein B (gB) of herpes simplex virus and Epstein-Barr virus and gpII of varicella zoster virus has been identified by nucleotide sequencing. The gene has been expressed in recombinant vaccinia virus and the gene product recognized by monoclonal antibodies and human immune sera. Rabbits immunized with the recombinant vaccinia virus produced antibodies that immunoprecipitate gB from HCMV-infected cells and neutralize HCMV infectivity in vitro. These data demonstrate a role for this protein in future HCMV vaccines.
- Published
- 1986
- Full Text
- View/download PDF